abagovomab 47
abciximab 42
abituzumab 31
abrilumab 29
actoxumab 29
adalimumab 22
aducanumab 17
afasevikumab 23
alacizumab_pegol 17
alemtuzumab 39
alirocumab 29
amatuximab 55
andecaliximab 31
anifrolumab 31
anrukinzumab 24
aprutumab 23
aprutumab_ixadotin 23
arcitumomab 29
ascrinvacumab 17
atezolizumab 17
atinumab 22
avelumab 20
basiliximab 51
bavituximab 50
begelomab 40
benralizumab 39
bevacizumab_beta 29
bezlotoxumab 29
bimagrumab 32
bleselumab 28
blinatumomab 47
blosozumab 38
bococizumab 27
brazikumab 21
brentuximab_vedotin 46
briakinumab 25
brodalumab 28
brolucizumab 32
brontictuzumab 35
burosumab 28
cabiralizumab 37
camrelizumab 17
canakinumab 30
cantuzumab_ravtansin 56
carlumab 27
carotuximab 37
cergutuzumab_amunaleukin2 37
cergutuzumab_amunaleukin 37
certolizumab_pegol 27
cetiximab 53
citatuzumab_bogatox 30
cixutumumab 46
clivatuzumab_tetraxetan 35
codrituzumab 41
conatumumab 22
concizumab 35
crenezumab 26
crizanlizumab 34
crotedumab 25
dacetuzumab 26
daclizumab 28
dalotuzumab 48
dapirolizumab_pegol 30
daratumumab 17
dectrekumab 13
demcizumab 38
denosumab 14
depatuxizumab 34
depatuxizumab_mafodotin 34
dezamizumab 31
dinutuximab 46
diridavumab 38
domagrozumab 20
drozitumab 31
duligotuzumab 21
durvalumab 20
dusigitumab 38
efalizumab 38
efungumab 38
eldelumab 23
elezanumab 34
elgemtumab 15
elotuzumab 23
emactuzumab 32
emapalumab 32
emibetuzumab 32
enavatuzumab 28
enfortumab_vedotin 16
enoblituzumab 25
enokizumab 34
enoticumab 26
ensituximab 47
eptinezumab 21
erenumab 33
etaracizumab 19
etrolizumab 25
evinacumab 25
evolocumab 35
farletuzumab 18
fasinumab 32
fezakinumab 35
fibatuzumab 27
ficlatuzumab 36
firivumab 43
flanvotumab 29
fletikumab 36
foralumab 21
foravirumab 19
fremanezumab 35
fresolimumab 26
fulranumab 26
futuximab 43
galcanezumab 28
ganitumab 38
gantenerumab 17
gemetuzumab 42
gemtuzumab2 38
gemtuzumab 43
gevokizumab 32
girentuximab 40
glembatumumab 30
glembatumumab_vedotin 30
guselkumab 31
ibalizumab 43
ibritumomab 50
icrucumab 21
idarucizumab 50
ifabotuzumab 27
imalumab 19
imgatuzumab 31
inclacumab 25
indatuximab_ravtansin 45
indusatumab 27
inebilizumab 35
intetumumab 25
iodine_girentuximab 33
ipilimumab 12
iratumumab 22
isatuximab 46
itolizumab 32
ixekizumab 43
labetuzumab_govitecan 34
lambrolizumab 36
lampalizumab 34
lanadelumab 19
landogrozumab 20
laprituximab 39
lebrikizumab 43
lendalizumab 31
lenzilumab 27
lifastuzumab_vedotin 27
ligelizumab 30
lilotomab 52
lirilumab 33
lodelcizumab 30
lokivetmab 30
lorvotuzumab_mertansin 31
lucatumumab 33
lumretuzumab 34
lupartumab 24
lutikizumab 23
margetuximab 49
milatuzumab 50
mirvetuximab 48
mirvetuximab_soravtansin 48
modotuximab 51
mogamulizumab 37
monalizumab 31
motavizumab 44
moxetumomab_pasudotox 36
namilumab 35
naratuximab 38
naratuximab_emtansin 38
narnatumab 25
navicixizumab2 38
navicixizumab 39
navivumab 45
necitumumab 20
nemolizumab 37
nesvacumab 21
nivolumab 21
obiltoxaximab 34
obinutuzumab 44
ocaratuzumab 32
ofatumumab 23
olaratumab 29
olokizumab 29
omalizumab 22
onartuzumab 27
ontuxizumab 40
opicinumab 17
orticumab 17
otelixizumab 45
oxelumab 15
ozanezumab 44
pamrevlumab 14
panobacumab 33
parsatuzumab 33
pasotuxizumab 23
pateclizumab 23
patritumab 34
pembrolizumab 36
perakizumab 26
pidilizumab 30
pinatuzumab_vedotin 19
plozalizumab 38
pogalizumab 31
polatuzumab_vedotin 24
ponezumab 47
prezalumab 18
pritoxaximab 53
quilizumab 23
racotumomab 43
radretumab 19
ralpancizumab 30
ramucirumab 17
ranevetmab 37
ranibizumab 29
refanezumab 35
remtolumab 22
rilotumumab 30
rinucumab 32
risankizumab 45
rituximab 36
rivabazumab 27
robatumumab 21
roledumab 38
romosozumab 34
rontalizumab 27
rosmantuzumab 34
rozanolixizumab 29
sacituzumab 40
sacituzumab_govitecan 40
samalizumab 33
sapelizumab 32
sarilumab 20
secukinumab 25
seribantumab 20
setoxaximab 55
sifalimumab 27
siltuximab 36
simtuzumab 37
sirukumab 18
solanezumab 29
solitomab 41
stamulumab 30
suptavumab 31
suvizumab 30
tabalumab 26
tadocizumab 26
tamtuvetmab 43
tanezumab 32
tarextumab 16
tavolixizumab 27
telisotuzumab 41
teplizumab 29
tesidolumab 41
tezepelumab 36
tigatuzumab 20
tildrakizumab 30
timolumab 21
tisotumab 17
tosatoxumab 53
tositumomab 49
tralokinumab 45
trastuzumab 25
tregalizumab 34
trevogrumab 16
ublituximab 42
urelumab 32
ustekinumab 34
utomilumab 39
vadastuximab 37
vadastuximab_talirin 37
vandortuzumab_vedotin 26
vantictumab 31
vanucizumab2 29
vanucizumab 49
varlilumab 21
vatelizumab 30
vedolizumab 41
veltuzumab 29
vesencumab 14
vorsetuzumab 37
vorsetuzumab_mafodotin 37
vunakizumab 49
xentuzumab 25
zatuximab 51
